[1]ZHU Anjie,YUAN Peng.New progress in targeted drug therapy for breast cancer[J].Chinese Journal of Clinicians,2018,46(04):381-384.[朱安婕,袁芃.乳腺癌靶向药物治疗新进展[J].中国临床医生杂志,2018,46(04):381-384.]
[2]SONG Erwei,GONG Chang,JIN Xin.Hot issues and reflections on breast cancer translational medicine research[J].Journl of Practical Medicine,2017,33(01):1-6.[宋尔卫,龚畅,金歆.乳腺癌转化医学研究的热点问题及思考[J].实用医学杂志,2017,33(01):1-6.]
[3]Chan C,Guo N,Duan X,et al.Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer[J].Biomaterials,2019,210(2):94-104.
[4]LI Xingjiang,CHEN Xiu,HE Yunji,et al.Progress of mirna-mediated cisplatin resistance in breast cancer[J].Chinese Journal of Cancer Surgery,2017,9(06):393-397.[李兴江,陈秀,何蕴藉,等.MiRNA介导乳腺癌顺铂耐药的相关机制进展[J].中国肿瘤外科杂志,2017,9(06):393-397.]
[5]Mandujano-Tinoco EA,García-Venzor A,Melendez-Zajgla J.New emerging roles of microRNAs in breast cancer[J].Breast Cancer Res Treat,2018,171(2):247-259.
[6]Zhang Y,Shen WL,Shi ML,et al.Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer[J].Biochim Biophys Acta,2015,1853(2):481-488.
[7]Qiu G,Lin Y,Zhang H,et al.miR-139-5p inhibits epithelial-mesenchymal transition,migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2[J].Biochem Biophys Res Commun,2015,463(3):315-321.
[8]ZHOU Dongmei,ZHANG Rui,HUA Wei,et al.miRNA-139-5p and tumor[J].Advances in Modern Biomedicine,2018,18(14):2780-2783.[周冬梅,张瑞,滑玮,等.miRNA-139-5p与肿瘤[J].现代生物医学进展,2018,18(14):2780-2783.]
[9]Dai X,Xiang L,Li T,et al.Cancer hallmarks,biomarkers and breast cancer molecular subtypes[J].J Cancer,2016,7(10):1281-1294.
[10]LI Jia,WANG Benzhong.Research progress of MicroRNA in breast cancer[J].Anhui Medicine,2011,32(12):2088-2090.[李佳,王本忠.MicroRNA在乳腺癌中的研究进展[J].安徽医学,2011,32(12):2088-2090.]
[11]MO Lirong,YANG Jinfang,LI Xue,et al.Advances in research on biomarkers of gastric cancer[J].Medical Eeview,2019,11(07):1327-1331,1337.[莫丽蓉,杨金芳,李雪,等.胃癌生物学标志物的相关研究进展[J].医学综述,2019,11(07):1327-1331,1337.]
[12]PAN Yasi,YU Baoping.Research progress on the clinical application of circulating microRNA in colorectal cancer[J].Journal of Medical Research,2018,47(10):4-6.[潘雅斯,余保平.循环microRNA在结直肠癌临床应用的研究进展[J].医学研究杂志,2018,47(10):4-6.]
[13]MI Siqian,HU Xiaoxia.Research progress of MEG3 with long non-coding RNA in cervical cancer[J].Progress in Modern Obstetrics and Gynecology,2019,33(05):396-398.[米思倩,胡晓霞.长链非编码RNA MEG3在宫颈癌中的研究进展[J].现代妇产科进展,2019,33(05):396-398.]
[14]CHEN Chang,WANG Xuelian.Research progress of circRNAs and their relationship with tumor[J].Chin J Etiol Biol,2016,11(12):1140-1143.[陈畅,王雪莲.环状RNA及其与肿瘤关系的研究进展[J].中国病原生物学杂志,2016,11(12):1140-1143.]
[15]ZHANG Li,LIU Shiyi,WANG Yanqing,et al.Research progress of lncRNA as ceRNA in ovarian cancer[J].International Journal of Reproductive Health/family Planning,2019,12(03):226-229.[张莉,刘诗意,王艳清,等.lncRNA作为ceRNA在卵巢癌中的研究进展[J].国际生殖健康/计划生育杂志,2019,12(03):226-229.]
[16]Liu H,Yin Y,Hu Y,et al.miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1[J].Pathol Res Pract,2016,212(7):643-649.
[17]Xu W,Hang M,Yuan CY,et al.MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer[J].Int J Clin Exp Pathol,2015,8(4):3864-3870.
[18]Chen H,Zhang H,Meng YG,et al.miR-139-5p regulates proliferation,apoptosis,and cell cycle of uterine leiomyoma cells by targeting TPD52[J].Onco Targets Ther,2016,11(9):6151-6160.
[19]Zhang X,Zhao X,Shao S,et al.Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role[J].Int J Oncol,2015,46(3):1141-1148.
[20]Bolos V,Mira E,Martine-Povead B,et al.Notch activation stimulates migration of breast cancer cells and promotes tumor growth[J].Breast Cancer Res,2013,15(4):R54.
[21]Suman S,Das TP,Damodaran C.Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells[J].Br J Cancer,2013,109(10):2587-2596.
[22]Pan H,Zhou W,He W,et al.Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-kappaB activity via the Notch-1 pathway[J].Int J Mol Med,2012,30(2):337-343.